Ming–Yang Lai

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C

Stefan Zeuzem, S.V. Feinman, J. Rasenack et al. · New England Journal of Medicine · 2000 · 1.2K citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

Jia‐Horng Kao, Pei‐Jer Chen, Ming–Yang Lai et al. · Gastroenterology · 2000 · 940 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers

Jia‐Horng Kao, Pei‐Jer Chen, Ming–Yang Lai et al. · Gastroenterology · 2003 · 532 citations · Full text

Medicine, Genetics, Molecular Genetics +15

A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin

Mark G. Swain, Ming–Yang Lai, Mitchell L. Shiffman et al. · Gastroenterology · 2010 · 326 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion.

S L Tsai, Pei‐Jer Chen, Ming–Yang Lai et al. · Journal of Clinical Investigation · 1992 · 291 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13